This episode explores the FDA’s regulatory pathways for medical device clearance and approval, peeling back the layers of risk-based classification and submission strategies. From simple class I devices like elastic bandages to high-stakes class III implants, the discussion walks listeners through how the FDA applies escalating levels of scrutiny depending on patient risk. The episode introduces essential regulatory frameworks including 21 CFR Parts 820, 801, 803, 812, and 814, and explains how manufacturers determine whether their device follows the 510(k), PMA, or De Novo pathway. Real-world examples help ground these regulatory constructs, making complex terms like “substantial equivalence,” “predicate device,” and “investigational device exemption” accessible to listeners.

In addition to U.S. pathways, the episode touches on global regu ...